Atmatzidis K, Papaziogas B, Mirelis C, Pavlidis T, Papaziogas T
2nd Surgical Clinic of the Aristotle University of Thessaloniki, Thessaloniki, Greece.
Dig Surg. 2003;20(6):527-31. doi: 10.1159/000073689. Epub 2003 Sep 24.
BACKGROUND/AIMS: The spleen is the third most common location of hydatid disease after liver and lung. The aim of this study was to analyse the long-term outcome of surgical treatment of patients with splenic echinococcosis comparing splenectomy with spleen-preserving surgery.
During a period of 25 years (1976-2001), 19 (5.4%) patients with splenic echinococcosis were treated in our department out of 349 patients with abdominal hydatid disease. In 16 patients the spleen was the only organ involved, while in 3 patients the liver was also affected.
Eleven patients had splenectomy and in the other 8 the spleen was preserved: enucleation (n = 4), partial cystectomy and omentoplasty (n = 2) and cystojejunal Roux-en-Y anastomosis (n = 2). One (6%) patient died in the early postoperative period and 5 (29%) patients had postoperative complications. There was no significant difference between the splenectomy and spleen-preserving groups concerning median hospital stay and postoperative complication rate. The median follow-up in 15 patients was 52 (range 6-300) months. Two patients (13%) developed recurrence of the disease requiring re-operation at 2 and 3 years, respectively. Recurrence occurred in 1 (12%) patient in the splenectomy group and in 1 (14%) out of 7 patients in the spleen-preserving group.
In the present series it was possible to preserve the spleen in 8 (42%) of 19 patients, without significant increase of recurrent echinococcosis.
背景/目的:脾脏是继肝脏和肺之后包虫病第三常见的发病部位。本研究的目的是分析脾包虫病患者手术治疗的长期结果,比较脾切除术和保脾手术。
在25年期间(1976 - 2001年),我们科室收治了349例腹部包虫病患者,其中19例(5.4%)为脾包虫病患者。16例患者脾脏是唯一受累器官,3例患者肝脏也受到影响。
11例患者接受了脾切除术,另外8例患者脾脏得以保留:摘除术(n = 4)、部分囊肿切除术加网膜成形术(n = 2)以及囊肿空肠Roux - Y吻合术(n = 2)。1例(6%)患者术后早期死亡,5例(29%)患者出现术后并发症。脾切除术组和保脾手术组在中位住院时间和术后并发症发生率方面无显著差异。15例患者的中位随访时间为52(6 - 300)个月。2例患者(13%)分别在术后2年和3年疾病复发需要再次手术。脾切除术组1例(12%)患者复发,保脾手术组7例患者中有1例(14%)复发。
在本系列研究中,19例患者中有8例(42%)成功保留了脾脏,且包虫病复发率没有显著增加。